Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaclyn F Hechtman

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Human Pathology|October 5, 2020
Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variantsSnjezana Dogan, Denise Frosina, Jerica A Geronimo, et al.
JCO Precision Oncology|September 11, 2020
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid TumorsEzra Y Rosen, Alison M Schram, Robert J Young, et al.
The American Journal of Surgical Pathology|July 19, 2017
Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK FusionsJaclyn F Hechtman, Ryma Benayed, David M Hyman, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2019
Reliable Clinical MLH1 Promoter Hypermethylation Assessment Using a High-Throughput Genome-Wide Methylation Array PlatformJamal K Benhamida, Jaclyn F Hechtman, Khedoudja Nafa, et al.
The American Journal of Surgical Pathology|February 7, 2022
Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine TumorsMegan Parilla, David Chapel, Jaclyn F Hechtman, et al.
Familial Cancer|April 14, 2017
Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerationsJaclyn F Hechtman, Sumit Middha, Zsofia K Stadler, et al.
Human Pathology|August 20, 2018
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGAJaclyn F Hechtman, Ghassan K Abou-Alfa, Zsofia K Stadler, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2022
Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attackZhikai Wang, Philip Moresco, Ran Yan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2015
Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)Jaclyn F Hechtman, Weiguo Liu, Justyna Sadowska, et al.
Oncotarget|June 2, 2016
Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinomaBreanna M Javier, Rona Yaeger, Lu Wang, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Human Pathology|October 5, 2020
Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variantsSnjezana Dogan, Denise Frosina, Jerica A Geronimo, et al.
JCO Precision Oncology|September 11, 2020
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid TumorsEzra Y Rosen, Alison M Schram, Robert J Young, et al.
The American Journal of Surgical Pathology|July 19, 2017
Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK FusionsJaclyn F Hechtman, Ryma Benayed, David M Hyman, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2019
Reliable Clinical MLH1 Promoter Hypermethylation Assessment Using a High-Throughput Genome-Wide Methylation Array PlatformJamal K Benhamida, Jaclyn F Hechtman, Khedoudja Nafa, et al.
The American Journal of Surgical Pathology|February 7, 2022
Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine TumorsMegan Parilla, David Chapel, Jaclyn F Hechtman, et al.
Familial Cancer|April 14, 2017
Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerationsJaclyn F Hechtman, Sumit Middha, Zsofia K Stadler, et al.
Human Pathology|August 20, 2018
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGAJaclyn F Hechtman, Ghassan K Abou-Alfa, Zsofia K Stadler, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2022
Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attackZhikai Wang, Philip Moresco, Ran Yan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2015
Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)Jaclyn F Hechtman, Weiguo Liu, Justyna Sadowska, et al.
Oncotarget|June 2, 2016
Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinomaBreanna M Javier, Rona Yaeger, Lu Wang, et al.
Pageof 12